AxoGen (AXGN) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free AXGN Stock Alerts $6.04 +0.07 (+1.17%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 2:27 PM | ca.finance.yahoo.comALGN May 2024 350.000 callMay 16, 2024 | finance.yahoo.comAxogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®May 16, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Sees Large Increase in Short InterestAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 1,820,000 shares, a growth of 9.0% from the April 15th total of 1,670,000 shares. Based on an average daily volume of 370,900 shares, the days-to-cover ratio is currently 4.9 days.May 14, 2024 | finance.yahoo.comAxogen, Inc to Participate at Leerink Partners Healthcare Crossroads ConferenceMay 9, 2024 | markets.businessinsider.comBuy Rating Upheld for AxoGen Amid Strong Financials and Innovative Growth StrategyMay 7, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Downgraded to "Hold" at StockNews.comStockNews.com cut AxoGen from a "buy" rating to a "hold" rating in a report on Monday.May 6, 2024 | finance.yahoo.comAxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call TranscriptMay 3, 2024 | finance.yahoo.comAxoGen First Quarter 2024 Earnings: Misses ExpectationsMay 3, 2024 | finance.yahoo.comAxogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst ChallengesMay 2, 2024 | msn.comAxoGen Non-GAAP EPS of -$0.06 beats by $0.01, revenue of $41.4M misses by $0.65MMay 2, 2024 | globenewswire.comAxogen, Inc Reports First Quarter 2024 Financial ResultsMay 1, 2024 | markets.businessinsider.comHere's what Wall Street expects from AxoGen's earnings reportMay 1, 2024 | finance.yahoo.comAxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the companyApril 30, 2024 | finanznachrichten.deAxogen, Inc.: Axogen Announces First Surgical Implants of Avive+ Soft Tissue MatrixApril 29, 2024 | globenewswire.comAxogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™April 16, 2024 | globenewswire.comAxogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024April 4, 2024 | finance.yahoo.comAnalysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before LongMarch 30, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Sees Significant Growth in Short InterestAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,700,000 shares, a growth of 21.4% from the February 29th total of 1,400,000 shares. Based on an average daily trading volume, of 427,600 shares, the short-interest ratio is currently 4.0 days. Currently, 4.2% of the shares of the company are sold short.March 26, 2024 | insidertrades.comAxoGen, Inc. (NASDAQ:AXGN) Insider Sells $35,159.04 in StockMarch 26, 2024 | insidertrades.comAxoGen, Inc. (NASDAQ:AXGN) CEO Karen L. Zaderej Sells 39,280 SharesMarch 25, 2024 | marketbeat.comErick Wayne Devinney Sells 4,578 Shares of AxoGen, Inc. (NASDAQ:AXGN) StockAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) insider Erick Wayne Devinney sold 4,578 shares of the stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of $7.68, for a total value of $35,159.04. Following the completion of the transaction, the insider now directly owns 165,661 shares in the company, valued at $1,272,276.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.March 11, 2024 | insidertrades.comGregory Gene Freitag Sells 25,000 Shares of AxoGen, Inc. (NASDAQ:AXGN) StockMarch 11, 2024 | insidertrades.comAxoGen, Inc. (NASDAQ:AXGN) VP Sells $319,891.10 in StockMarch 9, 2024 | finance.yahoo.comDirector Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)March 8, 2024 | marketbeat.comInsider Selling: AxoGen, Inc. (NASDAQ:AXGN) Director Sells 25,000 Shares of StockAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) Director Gregory Gene Freitag sold 25,000 shares of the stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $9.00, for a total transaction of $225,000.00. Following the transaction, the director now owns 271,594 shares in the company, valued at $2,444,346. The sale was disclosed in a filing with the SEC, which is available through this link.March 8, 2024 | finance.yahoo.comUS$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These ResultsMarch 7, 2024 | seekingalpha.comAxoGen, Inc. (AXGN) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | markets.businessinsider.comAxogen’s Strong Growth Prospects and Positive Analyst Outlook Prompt Buy Rating and Increased Price TargetMarch 6, 2024 | sg.finance.yahoo.comAxoGen, Inc. (AXGN) stock price, news, quote & history – Yahoo FinanceMarch 6, 2024 | finanznachrichten.deAxogen, Inc.: Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsMarch 6, 2024 | markets.businessinsider.comBuy Rating Affirmed: AxoGen’s Robust Growth and Market Potential Drive Positive OutlookMarch 6, 2024 | msn.comAxoGen files $100M mixed securities shelfMarch 6, 2024 | finance.yahoo.comAxoGen Full Year 2023 Earnings: Beats ExpectationsMarch 6, 2024 | finance.yahoo.comAxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | investing.comAxogen Inc (AXGN) Earnings Dates & ReportsMarch 5, 2024 | msn.comAxoGen Non-GAAP EPS of -$0.06 beats by $0.02, revenue of $42.9M beats by $1.9MMarch 5, 2024 | finance.yahoo.comAxogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023March 5, 2024 | globenewswire.comAxogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsMarch 4, 2024 | msn.comAxoGen Q4 2023 Earnings PreviewFebruary 23, 2024 | ca.finance.yahoo.comAmerican Well Corporation (AMWL)February 22, 2024 | benzinga.comAxogen Stock (NASDAQ:AXGN), Short Interest ReportFebruary 17, 2024 | finance.yahoo.comAXGN Mar 2024 12.500 callFebruary 16, 2024 | finance.yahoo.com3 Best Stocks to Buy for Remarkable Earnings AccelerationFebruary 14, 2024 | marketbeat.comTocqueville Asset Management L.P. Buys 464,500 Shares of AxoGen, Inc. (NASDAQ:AXGN)Tocqueville Asset Management L.P. boosted its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 98.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 934,900 shares of the medical equipment provider's stock after purcFebruary 13, 2024 | finance.yahoo.comAxogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024February 13, 2024 | globenewswire.comAxogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024February 12, 2024 | finance.yahoo.comHere's Why Momentum in AxoGen (AXGN) Should Keep goingFebruary 11, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Position Cut by Essex Investment Management Co. LLCEssex Investment Management Co. LLC lowered its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 23.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 296,440 shares of the medical equipment provideFebruary 9, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Rating Increased to Buy at StockNews.comStockNews.com upgraded AxoGen from a "hold" rating to a "buy" rating in a research report on Friday.February 8, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. lessened its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 77.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,988 shares of the medical Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. AXGN Media Mentions By Week AXGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXGN News Sentiment▼1.230.42▲Average Medical News Sentiment AXGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXGN Articles This Week▼42▲AXGN Articles Average Week Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EDAP News OM News SMLR News ZYXI News ELMD News FONR News VANI News HYPR News GLUE News DSGN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXGN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist My Default Watchlist Adding AxoGen, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
